STCBIOSTCBIO
STCBIO
  • About Us
    • Business Philosophy
      • Business Ideology
      • Business Principles
      • Vision
      • CI
    • Founder
      • Kye-Ho Lee
      • Social Contribution
    • STC Introduction
      • STC LIFE
      • STC NARA
      • bBHC
      • 97.7 B&H
    • History
    • How to Find Us
  • Research & Development
    • STRI
    • New Drug Research & Development Center
    • Agricultural Life Science Research Center
    • Life Science R&D Center
    • Gene Research Center
  • Major Products
    • ENERGY WATER
    • Cell97.7
    • CELGEN
    • LAMU
    • EIS
    • Customized Cosmetics
    • Food Supplements
  • PR
    • STC in News
    • STC PR
Menu back  
 
  • CORPORATE SITE LinkedIn
  • LANGUAGE
    • ENGLISH
    • KOREAN
    • CHINESE
    • CORPORATE SITE LinkedIn
    • About Us
      • Business Philosophy
        • Business Ideology
        • Business Principles
        • Vision
        • CI
      • Founder
        • Kye-Ho Lee
        • Social Contribution
      • STC Introduction
        • STC LIFE
        • STC NARA
        • bBHC
        • 97.7 B&H
      • History
      • How to Find Us
    • Research & Development
      • STRI
      • New Drug Research & Development Center
      • Agricultural Life Science Research Center
      • Life Science R&D Center
      • Gene Research Center
    • Major Products
      • ENERGY WATER
      • Cell97.7
      • CELGEN
      • LAMU
      • EIS
      • Customized Cosmetics
      • Food Supplements
    • PR
      • STC in News
      • STC PR
    December 9, 2014NewsBy stcbio

    A New Era Comes When Diabetes Can be Basically Treated Using Cells of Pancreas

    – STC Life succeeded in differentiating pluripotent stem cells without side effect into beta-cells of pancreas, for the first time in the world

    (SEOUL, SOUTH KOREA) STC Stem Cell Treatment & Research Institute(www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded, after conducting research projects for several years, in differentiating new pluripotent stem cells without side effect into beta-cells that control insulin in pancreas. These new pluripotent stem cells can be differentiated into any tissues or organs without adverse effects.

    Scientists at STC Stem Cell Treatment & Research Institute first created new pluripotent stem cells with no adverse effects and induced them to differentiate into beta-cells, and they identified their change into beta-cells 7 days thereafter. Then they identified generation of intact beta-cells by tracing insulin genes that typically appear in beta-cells.

    Along with success in differentiation of beta-cells, they also succeeded in differentiating into multiple cells in a short span of time. The research team led by Dr. Lee Sang-Yeon said that they generated beta-cells in these processes for the first time in the world.

    The research outcome is expected to be immediately applied to treating diabetes as it shows no adverse effects with outstanding safety.

    “With development of technology that can successfully differentiate STC pluripotent stem cells without side effect into beta-cells of pancreas, physicians now can treat basic cause of diseases rather than simply mitigating symptoms,” said Kye Ho Lee, Chairman of STC Life. “As we developed natural substances-based pluripotent stem cells (We refer to as STC EPN : Elicited pluripotent stem cell from natural compound) and technology of differentiating diverse cells using such stem cells, after successfully differentiating beta-cells for nerves, cartilages, liver, bone, fat and pancreas, we will be able to lead the world stem cell market. We will grow as the world top life science company by developing cell therapies with world leading technologies.”

    Established in 1989, STC Life is a life science company that concentrates resources on R&D of stem cells, genes related to controlling active oxygen in body (p62), life sciences, and energy water-based agriculture.

    STC Life developed Pluripotent stem cell without side effects, the first of its kind in the world, and it obtained a total of 58 patents in Korea and other countries, including 17 patents related with STC Pluripotent stem cells. It is also a therapy-oriented life science company that is treating incurable diseases and down-aging using mesenchymal stem cells at 97.7 B&H Clinic.

    With the mission of realizing vision and dream of bringing disease-free healthy life to people and extending lifespan while building a world with no poverty, STC Life will continuously develop new technologies to shape a better future.

    Contacts:

    STC Life Co., Ltd.

    Director, Minsun Oh

    +82 2 3438 0653

    msoh@stc365.com

    膵細胞利用により根本的治療の道が開かれる糖尿病 … STC Life、世界で初めて万能幹細胞から膵細胞への分化に成功

    http://www.businesswire.com/news/home/20141209005365/ja/#.VIay19KsW2U

    糖尿病,利用胞做根本性治的代已到

    http://www.businesswire.com/news/home/20141209005366/zh-CN/#.VIe4D6RxmUk

    糖尿病,利用臟細胞做根本性治療的時代已經到來

    http://www.businesswire.com/news/home/20141209005397/zh-HK/#.VIe4O6RxmUk

    http://www.businesswire.com/news/home/20141209005383/en/Era-Diabetes-Treated-Basically-Cells-Pancreas#.VIe4YKRxmUk

    Ein neues Zeitalter der Diabetesbehandlung durch Einsatz von Bauchspeicheldrsenzellen hat begonnen

    http://www.businesswire.com/news/home/20141209006488/de/#.VIe4hKRxmUk

    Inauguration d’une nouvelle re : traitement du diabte principalement l’aide des cellules pancratiques

    http://www.businesswire.com/news/home/20141209006489/fr/#.VIe4qKRxmUk

    Una Nueva Era Comienza Cuando se Puede Tratar la Diabetes, Bsicamente, con Clulas del Pncreas

    http://www.businesswire.com/news/home/20141209006490/es/#.VIe4yaRxmUk

    Uma nova era surge na qual o diabetes pode ser tratado basicamente com o uso de clulas do pncreas

    http://www.businesswire.com/news/home/20141209006492/pt/#.VIfKs6RxmUk

    Si apre di fatto una nuova era in cui il diabete potr essere trattato di fatto usando le cellule del pancreas

    http://www.businesswire.com/news/home/20141209005885/it/#.VIfK96RxmUk

    https://fr.finance.yahoo.com/actualites/inauguration-d-nouvelle-re-traitement-202200573.html(FR)

    http://markets.financialcontent.com/mng-ba.mercurynews/news/read?GUID=28864553&ChannelID=3191(EN)

    http://studio-5.financialcontent.com/mi.thestate/?GUID=&Page=MediaViewer&GUID=28864553&Page=MediaViewer&ChannelID=3191(EN)

    Onderzoekers veranderen pluripotente stamcellen in betacellen (Dutch)

    http://www.businesswire.com/news/home/20141209006765/nl/#.VIfLH6RxmUk

    http://www.me-newswire.net/ar/news/%D9%85%D8%B1%D8%B6-%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A-%D8%AD%D9%82%D8%A8%D8%A9-%D8%B9%D9%84%D8%A7%D8%AC-%D8%A3%D8%B3%D8%A7%D8%B3-%D8%A7%D9%84%D9%85%D8%B1%D8%B6-%D8%A8%D8%A7%D8%B3%D8%AA%D8%AE%D8%AF%D8%A7%D9%85-%D8%AE%D9%84%D8%A7%D9%8A%D8%A7-%D8%A7%D9%84%D8%A8%D9%86%D9%83%D8%B1%D9%8A%D8%A7%D8%B3/ar

    http://headlines.yahoo.co.jp/hl?a=20141210-00000023-jijc-biz

    http://www.excite.co.jp/News/economy_g/20141210/Jiji_20141210Y195.html

    http://fox.2ch.net/test/read.cgi/poverty/1418181332/l50/i

    http://2ch.hork.info/res/maguro.2ch.sc/poverty/1418181332

    http://b.hatena.ne discover this.jp/entry/www.businesswire.jp/news/jp/20141209005365/ja

    http://saisei-iryo.info/news/search_keyword.php?word=%93%EE%8D%9C%81E%93%EE%8D%9C%91%B9%8F%9D%81E%93%EE%8D%9C%8C%87%91%B9%8F%C7%81E%8AO%8F%9D%90%AB%93%EE%8D%9C%8C%87%91%B9%8F%C7%81E%93%EE%8D%9C%96%B3%8C%60%90%AC%8F%C7%81i%88%EA%97%97%81j

    http://shiraselab.com/2ch/?dat_id=1418181332

    BACK
    Related posts
    Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
    August 24, 2021
    Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report
    August 24, 2021
    Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature
    August 24, 2021
    No title
    July 31, 2020
    STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
    April 17, 2020
    460 patents regarding nEPS are registered in 147 countries.
    March 19, 2020
    PR
    • STC in News
    • STC PR
    • About Us
      • Business Philosophy
        • Business Ideology
        • Business Principles
        • Vision
        • CI
      • Founder
        • Kye-Ho Lee
        • Social Contribution
      • STC Introduction
        • STC LIFE
        • STC NARA
        • bBHC
        • 97.7 B&H
      • History
      • How to Find Us
    • Research & Development
      • STRI
      • New Drug Research & Development Center
      • Agricultural Life Science Research Center
      • Life Science R&D Center
      • Gene Research Center
    • Major Products
      • ENERGY WATER
      • Cell97.7
      • CELGEN
      • LAMU
      • EIS
      • Customized Cosmetics
      • Food Supplements
    • PR
      • STC in News
      • STC PR

    STC Group Co.,Ltd  |  72 UN Village-gil, Yongsan-gu Seoul (04420) South Korea
    TEL. 080-718-0120  |  FAX. 02-511-6419

    Copyright@2017 by STC Group Corporation Co.Ltd . All Rights reserved. Designed by NXweb

      • STRI
      • Energy water
      • All that skin
      Famliy Site